NET PROFIT (x1000 EUR)
EMPLOYEES
Fisher Scientific Biotech Line A/S
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
3,013,836
|
1,373
|
16,829 |
| Total assets |
10,621
|
1,662,397
|
1,063,813 |
| Current assets |
10,621
|
5,147
|
4,699 |
| Current liabilities |
8,728
|
10,311
|
9,366 |
| Equity capital |
1,893
|
1,652,086
|
1,054,447 |
| - share capital |
67
|
67
|
68 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
17.8%
|
99.4%
|
99.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
121.7%
|
49.9%
|
50.2% |
| Return on equity (ROE) |
159209.5%
|
0.1%
|
1.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.